Publication | Open Access
Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women
11
Citations
13
References
2022
Year
To date, this was the largest case-series study on the use of nicardipine for treating severe antepartum hypertension in pregnancy. We found that nicardipine could effectively and safely treat this condition. Based on its high success rate and acceptable safety profile, nicardipine should be considered a first-line treatment in women with severe hypertension in pregnancy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1